Cobio Diagnostics
Cobio Diagnostics is a biotechnology company dedicated to developing rapid, next-generation diagnostics for bacterial identification and antibiotic resistance detection using phage-amplified methods. Their innovative approach aims to address the global challenge of antimicrobial resistance by providing faster, cost-effective, and scalable diagnostic solutions that can be applied in various settings to improve patient outcomes and combat antibiotic resistance.
Industries
Nr. of Employees
small (1-50)
Products
Phage-amplified immunoassay for bacterial ID, AST, and MIC (96-well plate format)
A plate-based phage-amplified immunoassay that performs direct-from-specimen species-specific bacterial identification, phenotypic antimicrobial susceptibility testing, and quantitative MIC determination within a 2–5 hour timeframe using species-specific phages, anti-phage capture and reporter antibodies, and colorimetric ELISA readout.
Phage-amplified immunoassay for bacterial ID, AST, and MIC (96-well plate format)
A plate-based phage-amplified immunoassay that performs direct-from-specimen species-specific bacterial identification, phenotypic antimicrobial susceptibility testing, and quantitative MIC determination within a 2–5 hour timeframe using species-specific phages, anti-phage capture and reporter antibodies, and colorimetric ELISA readout.
Services
Strategic partnering and licensing arrangements with established diagnostics companies to enable manufacturing, sales, and distribution of assays.
Development and supply of species-specific phage cocktails and anti-phage capture/reporter antibodies for use in rapid phenotypic diagnostic assays.
Strategic partnering and licensing arrangements with established diagnostics companies to enable manufacturing, sales, and distribution of assays.
Development and supply of species-specific phage cocktails and anti-phage capture/reporter antibodies for use in rapid phenotypic diagnostic assays.
Expertise Areas
- Clinical diagnostics for bacterial identification and susceptibility
- Phenotypic antimicrobial susceptibility testing (AST/MIC)
- Phage-based assay development and reagentization
- Immunoassay (ELISA-format) development
Key Technologies
- Phage amplification assays
- Immunoassay (ELISA) capture and reporter antibody detection
- 96-well plate colorimetric detection
- Direct-from-specimen testing